ClinicalTrials.Veeva

Menu

Immobilization and Protein Supplementation (IM-PRO)

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Disuse Atrophy
Aging

Treatments

Behavioral: Immobilization

Study type

Interventional

Funder types

Other

Identifiers

NCT01588808
MEC 12-3-012

Details and patient eligibility

About

In the present study, the effects of 5 days of lower limb immobilization with or without twice-daily protein supplementation on muscle mass and muscle fiber characteristics will be determined. A young group will be included to compare the changes in muscle mass and muscle fiber characteristics between young and old men.

Enrollment

35 patients

Sex

Male

Ages

18 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male
  • Aged from 18-35 years and from 65-75 years
  • 18.5 < BMI < 30 kg/m2

Exclusion criteria

  • Smoking
  • Performing regular resistance training in the previous 6 months
  • Hypertension (according to WHO criteria) [52] and/or cardiovascular disease
  • Any back/leg/knee/shoulder complaints which may interfere with the use of crutches
  • Systemic use of antibiotics within 3 weeks prior to the study visit
  • Current systemic use of corticosteroids, growth hormone, testosterone, immunosuppressants or insulin
  • Type 2 diabetes mellitus
  • Any history of thrombosis
  • Any family history (1st grade) of thrombosis
  • All co-morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. arthritis, spasticity/rigidity, all neurological disorders and paralysis).
  • Myocardial infarction within the last 3 years
  • Use of anti-coagulants
  • Any (history of) gastrointestinal disease that interferes with GI function
  • Indications related to interaction with the study product:
  • Known allergy to milk or milk products
  • Known galactosemia

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

35 participants in 3 patient groups, including a placebo group

Immobilization with protein (elderly)
Active Comparator group
Description:
Immobilization with twice-daily protein supplementation - in the elderly
Treatment:
Behavioral: Immobilization
Immobilization without protein (elderly)
Placebo Comparator group
Description:
Immobilization without twice-daily protein supplementation - in the elderly
Treatment:
Behavioral: Immobilization
Immobilization without protein (young)
Active Comparator group
Description:
Immobilization without twice-daily protein supplementation - in the young
Treatment:
Behavioral: Immobilization

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems